National- and State-Level Pharmacy-Based Buprenorphine Dispensing, United States 2019–2021
Conflict of Interest:
The authors declare no competing interest.
Disclaimer:
The findings and conclusions in this paper are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Comments (0)